These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 8610762

  • 1. Human placental monoamine transporters as targets for amphetamines.
    Ramamoorthy JD, Ramamoorthy S, Leibach FH, Ganapathy V.
    Am J Obstet Gynecol; 1995 Dec; 173(6):1782-7. PubMed ID: 8610762
    [Abstract] [Full Text] [Related]

  • 2. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
    Wall SC, Gu H, Rudnick G.
    Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
    [Abstract] [Full Text] [Related]

  • 3. Lanthanides inhibit the human noradrenaline, 5-hydroxytryptamine and dopamine transporters.
    Bryan-Lluka LJ, Bönisch H.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):699-706. PubMed ID: 9205953
    [Abstract] [Full Text] [Related]

  • 4. Human placenta as a target organ for cocaine action: interaction of cocaine with the placental serotonin transporter.
    Prasad PD, Leibach FH, Mahesh VB, Ganapathy V.
    Placenta; 1994 Apr; 15(3):267-78. PubMed ID: 8066050
    [Abstract] [Full Text] [Related]

  • 5. Non-neurotoxic amphetamine derivatives release serotonin through serotonin transporters.
    Rudnick G, Wall SC.
    Mol Pharmacol; 1993 Feb; 43(2):271-6. PubMed ID: 8429828
    [Abstract] [Full Text] [Related]

  • 6. Use of human placenta in studies of monoamine transporters.
    Ganapathy V, Prasad PD, Leibach FH.
    Methods Enzymol; 1998 Feb; 296():278-90. PubMed ID: 9779455
    [No Abstract] [Full Text] [Related]

  • 7. Sodium- and chloride-dependent, cocaine-sensitive, high-affinity binding of nisoxetine to the human placental norepinephrine transporter.
    Jayanthi LD, Prasad PD, Ramamoorthy S, Mahesh VB, Leibach FH, Ganapathy V.
    Biochemistry; 1993 Nov 16; 32(45):12178-85. PubMed ID: 8218295
    [Abstract] [Full Text] [Related]

  • 8. Expression of a cocaine-sensitive norepinephrine transporter in the human placental syncytiotrophoblast.
    Ramamoorthy S, Prasad PD, Kulanthaivel P, Leibach FH, Blakely RD, Ganapathy V.
    Biochemistry; 1993 Feb 09; 32(5):1346-53. PubMed ID: 8448143
    [Abstract] [Full Text] [Related]

  • 9. Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors.
    Olivier B, Soudijn W, van Wijngaarden I.
    Prog Drug Res; 2000 Feb 09; 54():59-119. PubMed ID: 10857386
    [Abstract] [Full Text] [Related]

  • 10. Drugs of abuse and human placenta.
    Ganapathy V.
    Life Sci; 2011 May 23; 88(21-22):926-30. PubMed ID: 20932493
    [Abstract] [Full Text] [Related]

  • 11. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.
    Hall FS, Li XF, Sora I, Xu F, Caron M, Lesch KP, Murphy DL, Uhl GR.
    Neuroscience; 2002 May 23; 115(1):153-61. PubMed ID: 12401330
    [Abstract] [Full Text] [Related]

  • 12. Norepinephrine transporters in rat placenta labeled with [3H]nisoxetine.
    Shearman LP, Meyer JS.
    J Pharmacol Exp Ther; 1998 Feb 23; 284(2):736-43. PubMed ID: 9454822
    [Abstract] [Full Text] [Related]

  • 13. Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells.
    Siebert GA, Pond SM, Bryan-Lluka LJ.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar 23; 361(3):255-64. PubMed ID: 10731037
    [Abstract] [Full Text] [Related]

  • 14. Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters.
    Miller DK, Crooks PA, Zheng G, Grinevich VP, Norrholm SD, Dwoskin LP.
    J Pharmacol Exp Ther; 2004 Sep 23; 310(3):1035-45. PubMed ID: 15121762
    [Abstract] [Full Text] [Related]

  • 15. Design, synthesis, and monoamine transporter binding site affinities of methoxy derivatives of indatraline.
    Gu XH, Yu H, Jacobson AE, Rothman RB, Dersch CM, George C, Flippen-Anderson JL, Rice KC.
    J Med Chem; 2000 Dec 14; 43(25):4868-76. PubMed ID: 11123996
    [Abstract] [Full Text] [Related]

  • 16. Calmodulin-dependent regulation of the catalytic function of the human serotonin transporter in placental choriocarcinoma cells.
    Jayanthi LD, Ramamoorthy S, Mahesh VB, Leibach FH, Ganapathy V.
    J Biol Chem; 1994 May 20; 269(20):14424-9. PubMed ID: 8182048
    [Abstract] [Full Text] [Related]

  • 17. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
    Eshleman AJ, Carmolli M, Cumbay M, Martens CR, Neve KA, Janowsky A.
    J Pharmacol Exp Ther; 1999 May 20; 289(2):877-85. PubMed ID: 10215666
    [Abstract] [Full Text] [Related]

  • 18. Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters.
    Kocabas AM, Rudnick G, Kilic F.
    J Neurochem; 2003 Jun 20; 85(6):1513-20. PubMed ID: 12787070
    [Abstract] [Full Text] [Related]

  • 19. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C, Reither H, Hornykiewicz O.
    Eur J Pharmacol; 2015 May 15; 755():119-26. PubMed ID: 25771452
    [Abstract] [Full Text] [Related]

  • 20. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies.
    Bottalico B, Larsson I, Brodszki J, Hernandez-Andrade E, Casslén B, Marsál K, Hansson SR.
    Placenta; 2004 Jul 15; 25(6):518-29. PubMed ID: 15135235
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.